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ABSTRACT
We describe the creation process of the Minimum Information Specification for In Situ Hy-
bridization and Immunohistochemistry Experiments (MISFISHIE). Modeled after the ex-
isting minimum information specification for microarray data, we created a new specifica-
tion for gene expression localization experiments, initially to facilitate data sharing within a
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consortium. After successful use within the consortium, the specification was circulated to
members of the wider biomedical research community for comment and refinement. After
a period of acquiring many new suggested requirements, it was necessary to enter a final
phase of excluding those requirements that were deemed inappropriate as a minimum re-
quirement for all experiments. The full specification will soon be published as a version 1.0
proposal to the community, upon which a more full discussion must take place so that the
final specification may be achieved with the involvement of the whole community.
This paper is part of the special issue of OMICS on data standards.
INTRODUCTION
THE NIH/NIDDK Stem Cell Genome Anatomy Projects (SCGAP) funded seven groups with a commongoal of studying stem/progenitor cells in blood, bone, kidney, liver, gastrointestinal tract, prostate, and
bladder, and with a mandate to make all data generated rapidly available to each other and to the research
community via a public database (www.scgap.org/). This sharing and collaborative analysis of data will,
it is hoped, lead to greater insight into cell differentiation and organ development.
To share these data effectively, we agreed that a common set of standards for all large data types is
needed. Where such data standards already exist, such as those developed by Microarray Gene Expression
Data (MGED) Society (Ball and Brazma, this issue), we adopted them. MIAME (Brazma et al., 2001) de-
fines a specification of minimum information that must be provided for others to analyze independently
and to reproduce, if necessary, the results of microarray-based experiments. MAGE-OM/ML (Spellman et
al., 2002) defines an object model and markup language for encoding the information about a microarray
experiment. Following this example, we have defined MISFISHIE—the Minimum Information Specifica-
tion for In Situ Hybridization and Immunohistochemistry Experiments—for data generated from visual in-
terpretation-based studies, such as in situ hybridization and immunohistochemistry, in which protein and
gene transcript localizations (hereafter referred to as “gene expression localization experiments”) are de-
termined.
While no official minimum specification for such data yet exists, there have been several efforts at or-
ganizing gene expression localization data in databases and such database designs provide a useful frame-
work from which to build MISFISHIE. Two notable databases specialized for the mouse community—the
Mouse Gene Expression Database (GXD) (Hill et al., 2004) and the Edinburgh Mouse Atlas Gene Ex-
pression (EMAGE) database (Christiansen et al., 2006)—have influenced the design of MISFISHIE.
Following its successful use and refinement within the SCGAP consortium, we believe that MISFISHIE
may well be of benefit to the wider community of biomedical researchers. Therefore, we have been circu-
lating a draft manuscript describing MISFISHIE in detail to researchers and journal editors in order to build
a consensus on which pieces of information should be provided at minimum about such experiments.
CREATING A STANDARD
The MISFISHIE specification describes the types of information that should be provided for each gene
expression localization experiment organized in six sections: (1) Experimental Design, (2) Biomaterials and
Treatments, (3) Reporters, (4) Staining, (5) Imaging Data, and (6) Image Characterizations. A checklist is
provided for quick and easy reference, and to promote adherence to the specification. An article describing
MISFISHIE in detail is forthcoming (Deutsch et al., 2006).
The initial specification used in the consortium as we began generating data was fairly simple and some-
what variably interpreted. As it became more widely circulated, we entered a period of inflation, where the
specification acquired many new requirements suggested by researchers. However, there was soon consid-
erable alarm that MISFISHIE had become bloated with too many requirements. Thus, the final phase of its
development involved excluding those that are deemed inappropriate as a minimum requirement for all ex-
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periments. Many of these experimental parameters may well have some impact on the results of some ex-
periments, but we came to understand that they are irrelevant for many other experiments. Including them
in a minimum information specification would only serve to hinder acceptance of MISFISHIE by the com-
munity. This initial expansion and later contraction in response to criticism seemed to be a healthy process
in the formulation of a community-based specification.
As with any minimum information specification, there will inevitably be different views on what needs
to be listed in MISFISHIE. The more contentious requirements are how precisely the reporter should be
defined (e.g., must the exact probe sequence be provided), if an image of each assay should be provided,
and if and how interpretations of the images should be provided. Consensus requirements that pleased every-
one were not reached for these items, but after long discussions, we came to a point where most of those
who had voiced their opinions on these issues accepted the resultant effort as a workable specification.
Briefly, MISFISHIE describes the minimum information as (1) experimental design attributes such as a
brief description, the assay types, experimental factors (variables among the assays), and contact informa-
tion; (2) biomaterial attributes such as physical attributes, physiologic state, and relevant exogenous factors
associated with the individuals from which the specimens were obtained plus treatment protocols applied
to the specimen prior to staining; (3) reporter (probe or antibody) information, such as unambiguous re-
porter identification or sequence and protocol for obtaining the reporter; (4) staining protocol and parame-
ters including detection methods, reagents, and details about positive and negative controls; (5) imaging
data, at minimum one representative image per assay, that can be downloaded to a computer and explored;
and (6) image characterizations in a tabular form per assay using properly defined intensity scale and struc-
tural units (i.e., organs, glands, cell types).
Once we developed a complete draft of the specification and a simplified checklist, we tested MISFISHIE
by first having a dozen or so MISFISHIE authors review several recently published papers and compare
notes on their ratings for compliance. Next, a pool of a few dozen articles was assigned among these re-
viewers, each one tasked with assessing the articles for MISFISHIE compliance. The survey results were
compiled and are reported along with the specification (Deutsch et al., 2006). This exercise proved to be a
useful tool in refining the specification and identifying the more notable shortfalls in compliance in the cur-
rent literature.
We believe that it has been beneficial to separate the tasks of defining a minimum information specifi-
cation and a full-blown object model for this data type, as was done with MIAME and MAGE-OM. This
separation allowed contributors first to focus discussions on what information is necessary while deferring
the more difficult question of how to model the data to a later stage. Now that the minimum information
specification is well underway, we will develop an object model and ontology, building on the Functional
Genomics Experiment Object Model (FuGE-OM) (Jones et al., this issue) and Functional Genomics On-
tology (FuGO) (Whetzel et al., this issue)
In order to give our specification a permanent home in the larger community, a MISFISHIE working
group has been created within the MGED Society. This provides MISFISHIE with a permanent web pres-
ence (www.mged.org) and opportunities for discussion at MGED meetings, and involvement by researchers
familiar with the crafting of community-based standards for data sharing.
CONCLUSION
The full MISFISHIE specification is now ready for publication. If the manuscript is accepted, it will be-
come a version 1.0 proposal to the community. However, further discussions must take place as the even-
tual accepted standard cannot be dictated but must rather be reached by consensus. Suggestions from the
community are encouraged and will be collected and folded into a second release, to be promulgated at the
MISFISHIE area of the MGED website (http://mged.sourceforge.net/misfishie/). Comments may be ad-
dressed to the email distribution list dedicated to MISFISHIE (mged-misfishie@lists.sourceforge.net). If
a consensus on the minimum requirements in MISFISHIE can be achieved, and if the specification becomes
a requirement for publication, we think this will significantly improve the completeness of data reporting
and reusability of the data.
MISFISHIE
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